A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted radiopharmaceutical therapy (RPT) has enabled significant imaging and prostate-specific antigen (PSA) responses, accumulating clinical d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Boinapally, Srikanth, Ahn, Hye-Hyun, Cheng, Bei, Brummet, Mary, Nam, Hwanhee, Gabrielson, Kathleen L., Banerjee, Sangeeta R., Minn, Il, Pomper, Martin G.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007718/
https://ncbi.nlm.nih.gov/pubmed/33782486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86551-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars